It currently makes three drugs that contain semaglutide, including: Wegovy, a once-weekly injectable medicine for weight loss and cardiovascular risk reduction Ozempic, a once-weekly injectable medicine for Type 2 diabetes and cardiovascular risk reduction, often prescribed off-label (for a non-FDA-approved use) for weight loss Rybelsus, a daily oral medicine for managing blood sugar levels in people with Type 2 diabetes, and sometimes prescribed off-label for weight loss These three brand-name medicines are the only FDA-approved semaglutide products
Relapse drinking is a huge problem in patients with AUD [alcohol use disorder]
The most commonly reported adverse effects are gastrointestinal in nature, including nausea, diarrhea, vomiting, constipation, and abdominal pain
Trouble breathing, a rash, or swelling may show you have an allergic reaction and should not be ignored
Lower Risk of MACE and All-Cause Death in Patients Initiated on Semaglutide 2.4 mg in Routine Clinical Care: Results from the SCORE Study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)
Mounjaro or Wegovy: Which Is Better
